FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:526-528 February 14, 2002 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Editorial by Drazen, J. M. Letters Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Rosenthal, M. B. Related Article by Lee, T. H. PubMed Citation

It has been almost five years since the Food and Drug Administration (FDA) issued guidelines clarifying the agency's broadcast requirements for the advertising of specific pharmaceutical agents directly to consumers on television.¹ Previously, most direct-to-consumer advertising had been confined to newspapers and magazines. We think this expansion to television has been a positive step.

Does direct-to-consumer advertising strengthen or weaken the physician–patient relationship? Physicians should and do remain in control of prescribing medicines. As the article by Rosenthal et al. in this issue of the Journal² makes clear, pharmaceutical companies recognize this fact by directing a large proportion of their . . . [Full Text of this Article]

References

Related Letters:

Malposition of a Pacemaker Lead
Farzaneh-Far A., Firschke C., Zrenner B., Kastrati A.
Extract | Full Text | PDF  
N Engl J Med 2002; 346:2010, Jun 20, 2002. Correspondence

Direct-to-Consumer Marketing
Weinberg S. K., Ackman D., Glied S., Nunes J. P. L., Hurst J. W., Ehrlich J. E., Rumberger J. A., Wasserman A. G., Rosenthal M., Frank R. G., Epstein A. M., Lee T. H., Brennan T. A., Wolfe S. M.
Extract | Full Text | PDF  
N Engl J Med 2002; 346:2010-2013, Jun 20, 2002. Correspondence

This article has been cited by other articles:

• Davis, J. J. (2007). Consumers' Preferences For The Communication Of Risk Information In Drug Advertising. Health Aff (Millwood) 26: 863-870 [Abstract] [Full Text]  
• Jagsi, R. (2007). Conflicts of Interest and the Physician-Patient Relationship in the Era of Direct-to-Patient Advertising. JCO 25: 902-905 [Full Text]  
• Frosch, D. L., Krueger, P. M., Hornik, R. C., Cronholm, P. F., Barg, F. K. (2007). Creating Demand for Prescription Drugs: A Content Analysis of Television Direct-to-Consumer Advertising. Ann Fam Med 5: 6-13 [Abstract] [Full Text]  
• Huskamp, H. A. (2006). Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value.. Health Aff (Millwood) 25: 635-646 [Abstract] [Full Text]  
• Hollon, M. F. (2005). Direct-to-Consumer Advertising: A Haphazard Approach to Health Promotion. JAMA 293: 2030-2033 [Full Text]  
• Larson, R. J., Schwartz, L. M., Woloshin, S., Welch, H. G. (2005). Advertising by Academic Medical Centers. Arch Intern Med 165: 645-651 [Abstract] [Full Text]  
• Murray, E., Lo, B., Pollack, L., Donelan, K., Lee, K. (2004). Direct-to-Consumer Advertising: Public Perceptions of Its Effects on Health Behaviors, Health Care, and the Doctor-Patient Relationship. J Am Board Fam Med 17: 6-18 [Abstract] [Full Text]  
• Ellner, A. (2003). Rethinking prescribing in the United States. BMJ 327: 1397-1400 [Full Text]  
• Murray, E., Lo, B., Pollack, L., Donelan, K., Lee, K. (2003). Direct-to-Consumer Advertising: Physicians' Views of Its Effects on Quality of Care and the Doctor-Patient Relationship. J Am Board Fam Med 16: 513-524 [Abstract] [Full Text]  
• Gardner, D. M., Mintzes, B., Ostry, A. (2003). Direct-to-consumer prescription drug advertising in Canada: Permission by default?. CMAJ 169: 425-427 [Full Text]  
• Gray, S., Olopade, O. I. (2003). Direct-to-Consumer Marketing of Genetic Tests for Cancer: Buyer Beware. JCO 21: 3191-3193 [Full Text]  
• Illes, J., Fan, E., Koenig, B. A., Raffin, T. A., Kann, D., Atlas, S. W. (2003). Self-referred Whole-Body CT Imaging: Current Implications for Health Care Consumers. Radiology 228: 346-351 [Abstract] [Full Text]  
• Maynard, A., Bloor, K. (2003). Dilemmas In Regulation Of The Market For Pharmaceuticals. Health Aff (Millwood) 22: 31-41 [Abstract] [Full Text]  
• Mello, M. M., Rosenthal, M., Neumann, P. J. (2003). Direct-to-Consumer Advertising and Shared Liability for Pharmaceutical Manufacturers. JAMA 289: 477-481 [Full Text]  
• Weinberg, S. K., Ackman, D., Glied, S., Nunes, J. P. L., Hurst, J. W., Ehrlich, J. E., Rumberger, J. A., Wasserman, A. G., Rosenthal, M., Frank, R. G., Epstein, A. M., Lee, T. H., Brennan, T. A., Wolfe, S. M. (2002). Direct-to-Consumer Marketing. NEJM 346: 2010-2013 [Full Text]  
• Drazen, J. M. (2002). The Consumer and the Learned Intermediary in Health Care. NEJM 346: 523-524 [Full Text]